PMU28 - A CROSS INDICATION BUDGET IMPACT ANALYSIS OF SECUKINUMAB- A GREEK PERSPECTIVE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.1864
https://www.valueinhealthjournal.com/article/S1098-3015(18)35166-0/fulltext
Section Title :
Section Order :
1228
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35166-0&doi=10.1016/j.jval.2018.09.1864